Peter Hofland, PhD
  • Male
  • Chandler, AZ
  • United States

Profile Information

Professional (Medical) Affiliation
Medical Research, Pharma, Academia

Peter Hofland

Peter Hofland, PhD's Friends

  • Eberhard Rämisch
  • Tricia McEuen
  • Stacey Broucksou
  • Aileen Eiszele
  • Fabienne Douven
  • Zachary M Rathner
  • jane Walton
  • Kashif
  • Dr.Amin Delawalla
  • Kyu Lim
  • Frank
  • Danielle Friedman
  • Borsani Luisa
  • Dr mir khan
  • Sarah Krug

Gifts Received


Peter Hofland, PhD has not received any gifts yet

Give a Gift


Peter Hofland, PhD's Page

Comment Wall (2 comments)

You need to be a member of Onco'Zine to add comments!

Join Onco'Zine

At 12:04pm on January 28, 2013, Ryan Harris said…

This is a new way to network.

At 5:04pm on March 21, 2011, OncologyTube said…

Hi Peter -


Are you going to be at ASCO this year? I would love to meet you and perhaps talk more about some business ideas.


Allen Wilbanks


Peter Hofland, PhD's Photos

  • Add Photos
  • View All

Peter Hofland, PhD's Blog

The Critical Role Physicians Play in Ensuring Bladder Cancer Patients Understand the Link between Smoking and Their Disease

Posted on November 10, 2015 at 10:00am 0 Comments

When bladder cancer patients are well-informed by their physicians, they acknowledge that tobacco use was likely the cause of their disease. The finding comes from a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. Patients with such knowledge may be more motivated to quit smoking, which could help prolong their lives.

According the American Cancer Society, in the United States about 74,000 new cases of bladder…


Study Associates Gene Variant With Increased Risk and Severity of Nerve Disorder Linked to Widely-Prescribed Cancer Drug

Posted on February 24, 2015 at 11:00am 0 Comments

A study published in the February 24, 2015 issue of JAMA, the Journal of The American Medical Association, suggests that children with acute lymphoblastic leukemia who had a certain gene variant experienced a higher incidence and severity of peripheral neuropathy after receiving treatment with the cancer drug vincristine (Oncovin®/ Vincasar Pfs®).

Despite major advances over the last 2 decades, cancer remains the leading cause of death by disease in children in the United…


Researchers Identify Biomarkers and Combination Therapies that Hone Path to ONC201 Clinical Success

Posted on February 20, 2015 at 1:00pm 0 Comments

ONC201 is a small molecule inducer of the TRAIL gene under current investigation as a novel anticancer agent. The small molecule drug has a unique mechanism of action that causes significant anti-tumor activity in a variety of types of human cancer.

In an article published OnlineFirst on February 13, 2015 in Cancer Research, a journal published by the American Association for Cancer Research (AACR), Professor Wafik El-Deiry, MD, PhD, FACP, Co-Program Leader of Molecular…


Study Shows that Not All Women with Breast Cancer Understand the Details About their Condition

Posted on January 29, 2015 at 9:30am 0 Comments

A new analysis has found that many women with breast cancer lack knowledge about their illness, with minority patients less likely than white patients to know and report accurate information about their tumors’ characteristics.

Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings highlight the need to educate patients about their…


First-line Treatment with Panitumumab + FOLFOX in Patients with Wild-type KRAS Metastatic Colorectal Cancer Approved

Posted on May 23, 2014 at 5:30pm 0 Comments

The U.S. Food and Drug Administration (FDA) has approved panitumumab (Vectibix®, Amgen) for use in combination with FOLFOX, an oxaliplatin-based chemotherapy regimen, as first-line treatment in patients with wild-type KRAS (exon 2) metastatic colorectal cancer (mCRC). 

With an estimated number of 96,830 colon and 40,000…


Thank you Selma!

Posted on May 21, 2014 at 8:00pm 0 Comments

Just a little more than a week before the start of the 50th Annual Meeting of ASCO, the American Society of Clinical Oncology in Chicago, Il, the news landed on my desk that Selma Schimmel, founder and CEO of Vital Options International and an outspoken activist, patient advocate, respected radio talk show host and author had died, aged 59, from malignant psoas syndrome or MPS, a…


Revisiting Cardiac Screening Guidelines for Survivors of Childhood Cancer: Less Frequent Screening may be Beneficial

Posted on May 19, 2014 at 3:00pm 0 Comments

One of the first studies to analyze the effectiveness of screening survivors of childhood cancer for early signs of impending Congestive Heart Failure or CHF finds improved health outcomes. Hoever, the study suggests that less frequent screening than currently recommended may yield similar clinical benefit. The researchers, in a study published in the Annals of Internal Medicine, utilized a simulation-based…


Ultra-sensitive Nano-chip Capable of Detecting Early-stage Cancer

Posted on May 18, 2014 at 1:00pm 0 Comments

The majority of cancers today are detected on the macroscopic level, when the tumor already includes millions of cancer cells and the disease is starting to advance into a more mature phase. But what if we could diagnose cancer before it took hold- while it was still only affecting a few localized cells? It could be compared to putting a fire out while there are just a few sparks.

An international team of researchers, led by…


The Success of Tobacco Control: Study Shows Global Drop in Lung Cancer Rates in Young Women

Posted on May 16, 2014 at 10:30pm 0 Comments

A study published this week as an early online publication in Cancer Epidemiology, Biomarkers & Prevention shows that according to a recent comprehensive analysis of lung cancer rates for women around the world lung cancer rates are dropping in young women in many regions of the globe. The authors of the article suggest that their data points to the success of tobacco control efforts.

However, the data also shows that rates continue to increase among older women in many…


Experts Find New Ways to Predict Response to Chemo in Triple-negative Breast Cancer

Posted on May 16, 2014 at 2:00pm 0 Comments

Researchers from University Hospitals (UH) Case Medical Center's Seidman Cancer Center found that the presence of tumor-infiltrating lymphocytes, a type of white blood cell, ahead of treatment, may help predict response to platinum-based chemotherapy in women with triple-negative breast cancer. The data, which comes from the PrECOG 0105 trial, will be presented at the 50th annual meeting of the American Society for Clinical…


Register for free to view all the Onco'Zine - The International Oncology Network content:


Onco'Zine is present here

Bookmark / Share



© 2015   Created by Peter Hofland, PhD.   Powered by

Badges  |  Report an Issue  |  Terms of Service

Find us on Google+